Jan-Henrik Terwey

Jan-Henrik Terwey is a seasoned professional in the pharmaceutical industry with extensive experience in medical affairs and clinical development. Currently serving as VP and Head of Medical Affairs for Europe at BeiGene, Jan-Henrik has held significant leadership roles at Atara Biotherapeutics, including VP of Clinical Sciences and Global Development Lead for Allogeneic CAR-T Programs, as well as Global Head of Medical Affairs. Jan-Henrik's earlier career at Amgen included positions as Medical Director for Switzerland and International Development and Therapeutic Area Head for Oncology and Hematology. Training as a resident doctor at Universitätsklinikum Hamburg Eppendorf laid the foundation for Jan-Henrik's expertise. Jan-Henrik Terwey holds a Diploma of Advanced Studies in Pharmaceutical Medicine from the European Center of Pharmaceutical Medicine, complementing academic education received at The University of Göttingen.